NO163039C - Monoklonale antistoffer som er reaktive med delte idiotyper paa humane antistoffer overfor naturlig forekommende dnafra pasienter med systemisk lupus erythematosus for anvendelse ved in vitro-diagnostisering av sle-antistoffer. - Google Patents

Monoklonale antistoffer som er reaktive med delte idiotyper paa humane antistoffer overfor naturlig forekommende dnafra pasienter med systemisk lupus erythematosus for anvendelse ved in vitro-diagnostisering av sle-antistoffer.

Info

Publication number
NO163039C
NO163039C NO834434A NO834434A NO163039C NO 163039 C NO163039 C NO 163039C NO 834434 A NO834434 A NO 834434A NO 834434 A NO834434 A NO 834434A NO 163039 C NO163039 C NO 163039C
Authority
NO
Norway
Prior art keywords
idiotes
diagnostizing
sleep
vitro
patients
Prior art date
Application number
NO834434A
Other languages
English (en)
Norwegian (no)
Other versions
NO834434L (no
NO163039B (no
Inventor
Betty Ann Diamond
Original Assignee
Univ Yeshiva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yeshiva filed Critical Univ Yeshiva
Publication of NO834434L publication Critical patent/NO834434L/no
Publication of NO163039B publication Critical patent/NO163039B/no
Publication of NO163039C publication Critical patent/NO163039C/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/686Anti-idiotype
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104Lupus erythematosus [SLE]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/824Immunological separation techniques
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813Carrier is a saccharide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO834434A 1982-12-03 1983-12-02 Monoklonale antistoffer som er reaktive med delte idiotyper paa humane antistoffer overfor naturlig forekommende dnafra pasienter med systemisk lupus erythematosus for anvendelse ved in vitro-diagnostisering av sle-antistoffer. NO163039C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44671882A 1982-12-03 1982-12-03
US06/552,290 US4692416A (en) 1982-12-03 1983-11-16 Monoclonal antibodies reactive with shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus

Publications (3)

Publication Number Publication Date
NO834434L NO834434L (no) 1984-06-04
NO163039B NO163039B (no) 1989-12-11
NO163039C true NO163039C (no) 1990-03-21

Family

ID=27034715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834434A NO163039C (no) 1982-12-03 1983-12-02 Monoklonale antistoffer som er reaktive med delte idiotyper paa humane antistoffer overfor naturlig forekommende dnafra pasienter med systemisk lupus erythematosus for anvendelse ved in vitro-diagnostisering av sle-antistoffer.

Country Status (11)

Country Link
US (1) US4692416A (fr)
EP (1) EP0113431B1 (fr)
AU (1) AU566246B2 (fr)
CA (1) CA1215009A (fr)
DE (1) DE3382009D1 (fr)
DK (1) DK557383A (fr)
ES (1) ES8607024A1 (fr)
FI (1) FI834424L (fr)
IL (1) IL70366A (fr)
NO (1) NO163039C (fr)
NZ (1) NZ206467A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536479A (en) * 1983-03-22 1985-08-20 E. I. Du Pont De Nemours And Company Use of anti-idiotype antibodies in immunoassays
US4731237A (en) * 1983-11-07 1988-03-15 The Wistar Institute Immune response to virus induced by anti-idiotype antibodies
EP0141783B2 (fr) * 1983-11-07 1993-06-16 The Wistar Institute Réponse immune à des tumeurs et des virus induite par des anticorps anti-idiotypes
JPS61205862A (ja) * 1985-03-08 1986-09-12 Shionogi & Co Ltd アレルゲン特異IgG抗体測定用試薬
US4865970A (en) * 1986-02-28 1989-09-12 Hoffmann-La Roche Inc. Method of detecting ribosomal protein antibodies in systemic lupus erythematosus
DE3609271A1 (de) * 1986-03-19 1987-09-24 Boehringer Mannheim Gmbh Verfahren und reagenz zum nachweis von autoimmunerkrankungen, arzneimittel zur behandlung von autoimmunerkrankungen sowie hierzu geeignete antiparatypische antikoerper
CA1341277C (fr) * 1987-03-16 2001-07-31 Roland Keith Mcgready Anticorps anti-paratopique et son procede de fabrication
US5428132A (en) * 1987-10-11 1995-06-27 United States Of America Conjugate and method for integration of foreign DNA into cells
PT89107A (pt) * 1987-11-30 1989-11-30 Idec Pharma Corp Metodo e meios para a seleccao de anticorpos anti-idiotipos e seu uso para o diagnostico, monitorizacao, tratamento e/ou prevencao de doencas cancerosas, da autoimunidade ou infecciosas
US6232444B1 (en) 1990-01-29 2001-05-15 The Regents Of The University Of California Conserved anti-DNA antibody idiotype associated with nephritis in murine and human lupus
AU8083591A (en) * 1990-06-08 1991-12-31 Symbicom Aktiebolag Therapy and prophylaxis of autoimmune diseases
US7888458B1 (en) 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
WO1996037225A1 (fr) * 1995-05-25 1996-11-28 Oklahoma Medical Research Foundation Procede de traitement du lupus erythemateux dissemine
US7273613B1 (en) 1997-01-13 2007-09-25 The Board of Regents, The University of Oklahoma Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
TWI434855B (zh) * 2006-11-21 2014-04-21 Hoffmann La Roche 結合物及其在免疫分析中作為參考標準之用途
JP2010534335A (ja) * 2007-07-24 2010-11-04 アイエスエス イミューン システム スティミュレーション アーベー 全身性エリテマトーデス感受性を予測するための方法及び手段
US8283408B2 (en) 2010-02-26 2012-10-09 Hexcel Corporation Thermoplastic-toughened cyanate ester resin composites with low heat release properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234563A (en) * 1978-06-02 1980-11-18 American Hospital Supply Corporation Insolubilized deoxyribonucleic acid (DNA)
US4493899A (en) * 1981-10-16 1985-01-15 City Of Hope Method of testing for particular antibodies in the serum of a patient
DE3364347D1 (en) * 1982-04-09 1986-08-07 Fujirebio Kk Anti immune complex antibody and preparation thereof
US4487830A (en) * 1982-05-14 1984-12-11 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies

Also Published As

Publication number Publication date
FI834424A0 (fi) 1983-12-02
IL70366A (en) 1987-11-30
DE3382009D1 (de) 1991-01-03
DK557383D0 (da) 1983-12-02
ES527730A0 (es) 1986-06-16
IL70366A0 (en) 1984-03-30
CA1215009A (fr) 1986-12-09
FI834424A7 (fi) 1984-06-04
FI834424L (fi) 1984-06-04
NO834434L (no) 1984-06-04
US4692416A (en) 1987-09-08
AU566246B2 (en) 1987-10-15
EP0113431A3 (en) 1986-08-27
EP0113431A2 (fr) 1984-07-18
AU2171283A (en) 1984-06-07
EP0113431B1 (fr) 1990-11-22
NO163039B (no) 1989-12-11
ES8607024A1 (es) 1986-06-16
NZ206467A (en) 1986-11-12
DK557383A (da) 1984-06-04

Similar Documents

Publication Publication Date Title
NO163039C (no) Monoklonale antistoffer som er reaktive med delte idiotyper paa humane antistoffer overfor naturlig forekommende dnafra pasienter med systemisk lupus erythematosus for anvendelse ved in vitro-diagnostisering av sle-antistoffer.
DE3070944D1 (en) Method for the assay of classes of antigen-specific antibodies
ES488927A0 (es) Metodo para la recogida de plasma sanguineo.
ES519747A0 (es) Dispositivo para la introduccion de tampones, especialmente tampones catameniales y proceso y utiles para su fabricacion.
TR21430A (tr) Yeni siklohekzan-1-3-dion t*revleri, bunlarin hazirlanmasina mahsus usuller ve bunlarin herbisit olarak kullanimi
DK419283D0 (da) Alkoholsubstituerede amider, fremgangsmade til fremstilling heraf samt anvendelse ved fremstilling af stoebebare polyurethanelastomerer
ES252861Y (es) Mecanismo para cinturones de seguridad y similares.
IL62267A0 (en) Labeled antibodies,compositions containing them and methods for the use thereof
DK88183A (da) Biokemisk aktivt stof, fremgangsmaade til fremstilling heraf samt midler med indhold af stoffet
IL70746A0 (en) Specific cea-family antigens,antibodies specific thereto and methods for the use thereof
NL187069C (nl) N-acyl 3-(1-amino-3-methylbutyl)-8-hydroxy-3,4-dihydro-isocoumarine verbinding, werkwijze voor de bereiding daarvan en farmaceutisch preparaat.
JPS55142988A (en) Silencing separator with internal trap for liquid seallup blower or like
NO821103L (no) Fremgangsmaate for kontinuerlig fremstilling av vannloeselige fenol/formaldehydharpikser, samt apparat for fremgangsmaatens utfoerelse
ES515878A0 (es) "procedimiento y dispositivo para forrar piezas moldeadas".
NL7802023A (nl) Nieuwe geneesmiddelcombinaties alsmede werkwijze voor de bereiding daarvan.
DE3790139D2 (en) Antiparatypical antibodies, their use for detecting and treating auto-immune diseases
ES517630A0 (es) Sonda para la toma de gas caliente.
DK13787A (da) Apparat til brug ved afgivelse af saebe, creme eller lignende mere eller mindre viskose materialer
BE877136A (nl) Stellat en metalen klemorgaan, geschikt voor toepassing bij de stellat
IT7821760A0 (it) Conduttura per liquidi divisa in due parti, dotata di mezzi perl'accoppiamento fra le due parti della conduttura, specie per uso medicale.
DK274683A (da) Cystaminderivater, fremgangsmaade til fremstilling heraf samt midler med indhold heraf
ES268172Y (es) Mecanismo de fijacion para plataformas-contenedores abatibles y lisas.
Duderstadt Inglis House Faculty Dinners
IT8260386V0 (it) Piccoli mobili smontabili ecomponibili.
NO823431L (no) Fremgangsmaate ved vakuumpakking, samt apparat for anvendelse ved fremgangsmaaten